Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021
Corporate Participants:
Charles E. Triano — Senior Vice President, Investor Relations
Albert Bourla — Chairman and Chief Executive Officer
Mikael Dolsten — Chief Scientific Officer and President, Worldwide Research, Development and Medical
Angela Hwang — Group President, Pfizer Biopharmaceuticals Group
Frank D’Amelio — Chief Financial Officer and Executive Vice President, Global Supply
John Young — Group President, Chief Business Officer
Analysts:
David Risinger — Morgan Stanley — Analyst
Steve Scala — Cowen — Analyst
Gregg Gilbert — Truist Securities — Analyst
Louise Chen — Cantor Fitzgerald — Analyst
Umer Raffat — Evercore — Analyst
Geoffrey Porges — SVB Leerink — Analyst
Vamil Divan — Mizuho — Analyst
Tim Anderson — Wolfe Research — Analyst
Jason Zemansky — Bank of America — Analyst
Ronny Gal — Bernstein — Analyst
Navin Jacob — UBS — Analyst
Chris Schott — JPMorgan — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Earnings Preview: Intuitive Surgical (ISRG) looks poised for a strong Q4
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a pioneer in robotic-assisted surgical technology, developing advanced systems that enable healthcare professionals to perform minimally invasive procedures with greater precision and efficiency. Having
What to expect when Alaska Air Group (ALK) reports Q4 2025 earnings results
Shares of Alaska Air Group (NYSE: ALK) gained 3% on Thursday. The stock has dropped 26% in the past 12 months. The airline is scheduled to publish its earnings results
GS Earnings: A snapshot of Goldman Sachs’ Q4 2025 results
Banking giant Goldman Sachs Group, Inc. (NYSE: GS) on Thursday reported lower revenues and higher earnings for the fourth quarter of fiscal 2025. Net revenues decreased to $13.45 billion in
Listen On
